Reply to Banno et al and Padhi et al

Clin Infect Dis. 2022 Mar 23;74(6):1122-1123. doi: 10.1093/cid/ciab693.
No abstract available

Publication types

  • Comment

MeSH terms

  • COVID-19*
  • Humans
  • Ivermectin
  • Randomized Controlled Trials as Topic

Substances

  • Ivermectin